Essentials of Market Access for Pharmacy Benefit Therapies

This guide provides an in-depth exploration of market access strategies for pharmacy benefit therapies. It outlines the critical need for pharmaceutical companies to initiate market access planning 12-18 months prior to FDA approval to avoid potential pitfalls that can lead to unsuccessful product launches. The document details the roles of various stakeholders in the market access landscape, including payers and pharmacy benefits managers, and emphasizes the importance of defining and communicating a drug's clinical and economic value. It explains how formularies work, the decision-making processes of controllers, and the implications of utilization management policies. Additionally, the guide discusses the management of specialty drugs and the impact of new-to-market blocks on access to newly launched therapies. By providing a comprehensive understanding of these elements, the guide aims to equip market access teams with the knowledge necessary for successful commercialization.